Literature DB >> 6948814

Effects of extracellular calcium and of calcium antagonists on the contractile responses of isolated human pial and mesenteric arteries.

L Brandt, K E Andersson, L Edvinsson, B Ljunggren.   

Abstract

In isolated human pial arteries (diameter 0.4-0.5 mm), contractions were produced by potassium, noradrenaline, serotonin, and prostaglandin F2 alpha. For comparison, experiments were also performed on human mesenteric arteries. Threshold concentration for potassium-induced contraction in pial arteries was about 10 mM; in mesenteric arteries it was 3-5 mM higher. In pial arteries the calcium antagonists nifedipine and nimodipine caused an almost complete relaxation of contractions induced by potassium at drug concentrations relaxing prostaglandin F2 alpha-contracted vessels to only about 60%. Both nifedipine and nimodipine effectively inhibited contraction elicited by noradrenaline and serotonin in pial arteries. Nifedipine had a higher potency for relaxing cerebral than mesenteric arteries contracted by potassium (p less than 0.001). No such difference was demonstrated for nimodipine. In pial arteries pretreated in a calcium-free medium for 30 min, potassium depolarisation elicited contractions reaching a maximum amplitude of about 40% of that evoked in normal Krebs solution. Both nifedipine and nimodipine effectively inhibited contractions induced by calcium in pial arteries pretreated in a calcium-free medium and depolarised by potassium. The results suggest that potassium, amines, and prostaglandin F2 alpha activate isolated pial and mesenteric arteries by different calcium-dependent mechanisms and confirm the potent relaxant effects of nifedipine and nimodipine in these vessels.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6948814     DOI: 10.1038/jcbfm.1981.37

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  14 in total

1.  Compared effects of calcium entry blockers on calcium-induced tension in rat isolated cerebral and peripheral resistance vessels.

Authors:  G Julou-Schaeffer; J L Freslon
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-12       Impact factor: 3.000

2.  Comparison of the calcium entry blockers nimodipine and flunarizine on human cerebral and temporal arteries: role in cerebrovascular disorders.

Authors:  I Jansen; P Tfelt-Hansen; L Edvinsson
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  The haemodynamic effect of transcranial Doppler-guided high-dose nimodipine treatment in established vasospasm after subarachnoid haemorrhage.

Authors:  S C Zygmunt; T J Delgado-Zygmunt
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

4.  Influence of extracellular calcium and calcium antagonists on contractions induced by potassium and prostaglandin F2 alpha in isolated cerebral and mesenteric arteries of the cat.

Authors:  K E Andersson; L Edvinsson; E T MacKenzie; T Skärby; A R Young
Journal:  Br J Pharmacol       Date:  1983-05       Impact factor: 8.739

Review 5.  Nimodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cerebrovascular disease.

Authors:  M S Langley; E M Sorkin
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

6.  Discrete store-operated calcium influx into an intracellular compartment in rabbit arteriolar smooth muscle.

Authors:  R Flemming; A Cheong; A M Dedman; D J Beech
Journal:  J Physiol       Date:  2002-09-01       Impact factor: 5.182

7.  Calcium antagonists: effects on cerebral blood flow and blood-brain barrier permeability in the rat.

Authors:  L Edvinsson; B B Johansson; B Larsson; E T MacKenzie; T Skärby; A R Young
Journal:  Br J Pharmacol       Date:  1983-05       Impact factor: 8.739

8.  Oral nimodipine reduces prostaglandin and thromboxane production by arteries chronically exposed to a periarterial haematoma and the antifibrinolytic agent tranexamic acid.

Authors:  J D Pickard; V Walker; J Vile; S Perry; P J Smythe; R Hunt
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-06       Impact factor: 10.154

9.  Amelioration by the Ca2+ antagonist, nimodipine of an existing neuropathy in the streptozotocin-induced, diabetic rat.

Authors:  A C Kappelle; B Bravenboer; T van Buren; J Traber; D W Erkelens; W H Gispen
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

10.  Reversal of cerebral arterial spasm by intrathecal administration of a calcium antagonist (nimodipine).

Authors:  B Voldby; O F Petersen; M Buhl; P Jakobsen; R Ostergaard
Journal:  Acta Neurochir (Wien)       Date:  1984       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.